Journal Article |
| Ahuja SK,. Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy NEJM 2013 Jan;368(3):218-230.
|
| Martinez HG, Quinones MP, Jimenez F, Estrada C, Clark KM, Suzuki K, Miura N, Ohno N, Ahuja SK, Ahuja SS. Important role of CCR2 in a murine model of coronary vasculitis BMC Immunol 2012 Oct;13(1):56-56.
|
| Mamtani M, Anaya JM, He W, Ahuja SK. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases Genes Immun 2009 Sep;.
|
| Shostakovich-Koretskaya L, Catano G, Chykarenko ZA, He W, Gornalusse G, Mummidi S, Sanchez R, Dolan MJ, Ahuja SS, Clark RA, Kulkarni H, Ahuja SK. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children AIDS 2009 Mar;23(6):679-688.
|
| Gornalusse G, Mummidi S, He W, Silvestri G, Bamshad M, Ahuja SK. CCL3L Copy number variation and the co-evolution of primate and viral genomes PLoS Genet 2009 Jan;5(1):1000359-1000359.
|
| Camargo JF, Quinones MP, Mummidi S, Srinivas S, Gaitan AA, Begum K, Jimenez F, VanCompernolle S, Unutmaz D, Ahuja SS, Ahuja SK. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation J Immunol 2009 Jan;182(1):171-182.
|
| Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK, Delmar JA. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles PLoS ONE 2008 Nov;3(11):3636-3636.
|
| Mummidi S, Bonello GB, Ahuja SK. Confirmation of differential binding of Interferon Regulatory Factor-1 (IRF-1) to the functional and HIV disease-influencing -2578 A/G polymorphism in CCL2 Genes Immun 2008 Oct;.
|
| Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus Ann Rheum Dis 2008 Aug;67(8):1076-1083.
|
| He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK. Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility Cell Host Microbe 2008 Jul;4(1):52-62.
|
| Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, Dolan MJ, Ahuja SK. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations J Infect Dis 2008 Jul;198(1):72-80.
|
| Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression Proc Natl Acad Sci U S A 2008 Jun;105(25):8718-8723.
|
| Moore JP, Klasse PJ, Dolan MJ, Ahuja SK. AIDS/HIV. A STEP into darkness or light? Science 2008 May;320(5877):753-755.
|
| Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, OConnell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ, Kulkarni HR. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals Nat Med 2008 Apr;14(4):413-420.
|
| Camargo JF, Quinones M, Mummidi S, Srinivas S, Begum K, Jimenez F, Unutmaz D, Ahuja SS, Ahuja SK, VanCompernolle S. CCR5 expression levels influence positively NFAT transactivation, IL-2 production and subsequent events during T lymphocyte activation J Immunol. In Press 2008 Jan;.
|
| Quinones MP, Kalkonde Y, Estrada CA, Jimenez F, Ramirez R, Mahimainathan L, Mummidi S, Choudhury GG, Martinez H, Adams L, Mack M, Reddick RL, Maffi S, Haralambous S, Probert L, Ahuja SK, Ahuja SS. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt Mol Cell Neurosci 2008 Jan;37(1):96-109.
|
| Dolan MJ**, Kulkarni H**, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, OConnell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK (** These authors contributed equally as first authors. This article was accompanied by a commentary: Lederman MM, Sieg SF. CCR5 and its ligands: a new axis of evil? Nat Immunol. 2007;8(12):1283-5.). CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms Nat Immunol 2007 Dec;8(12):1324-1336.
|
| Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythematosus Ann Rheum Dis 2007 Nov;.
|
| Kalkonde YV, Morgan WW, Sigala J, MAFFI SK, Condello C, Kuziel W, Ahuja SS, Ahuja SK. Chemokines in the MPTP model of Parkinson''s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration Brain Res 2007 Jan;1128(1):1-11.
|
Abstract |
| Hilsabeck RC, Narayana S, Franklin C, Webb AL, Poy IG, Ali O, Stern SL, Fox PT, Ahuja SK. Brain Glucose Metabolism and Cognitive Performance after 12 weeks of Interferon-alpha Therapy; 2011 Jan. (Journal of International Neuropsychological Society; vol. 17, no. S1).
|
Not Specified |
| Ahuja SK, He W. Double-edged genetic swords and immunity: lesson from CCR5 and beyond J Infect Dis 2010 Jan;201(2):171-174.
|
| Mummidi S, Bonello GB, Ahuja SK. Confirmation of differential binding of Interferon Regulatory Factor-1 (IRF-1) to the functional and HIV disease-influencing -2578 A/G polymorphism in CCL2 Genes Immun 2009 Mar;10(2):197-198.
|
| Broliden K, Haase AT, Ahuja SK, Shearer GM, Andersson J. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts J Intern Med 2009 Jan;265(1):5-17.
|
| Ketas TJ, Kuhmann SE, Palmer A, Zurita J, He W, Ahuja SK, Klasse PJ, Moore JP. Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands Virology 2007 Aug;364(2):281-290.
|